Resolve Biosciences raises €63.9M Series B round
24 October 2022· Monheim am Rhein, Germany· health, biotech, ai, b2b, software_hardware
The funding will be used to rapidly scale operations and accelerate product development to meet the growing global demand for its Molecular Cartography technology.
Investors
LeadPatient Square Capital
Also participating
NRW.BankEDBIPS CapitalAlafi Capital
About Resolve Biosciences
Stage
Series B
Headquarters
Monheim am Rhein, Germany
Founded
2020
Team Size
51–200
Sectors
healthbiotechaib2bsoftware_hardware